International Patient Office - Asklepios Hospital Hamburg Altona

17/03/2020

The coronavirus affects us all - and with all the information available, it's easy to lose track. Here we have collected the most important points about COVID-19 for you.

Wir helfen weiter.

16/03/2020

DEAR VISITORS,

Unfortunately, we cannot allow relatives and visitors to enter our house at the moment due to the infection protection measures against the coronavirus or COVID-19.

We ask for your understanding!

To the background:
Please do not worry, our Patients receive the best possible care with us! Of course we know that you would like to be by the side of your loved ones now.

But we as a clinic are also subject to certain legal conditions and have a
special responsibility, the dissemination of the virus to the best of our ability.

The situation around the corona virus is developing anew every day - so it is possible that we will be able to lift the ban on visiting the site soon.

Further information about the coronavirus can also be found on our central website at www.asklepios.com/coronavirus

Your clinic management

16/12/2019

The Leading Medicine Guide informs about our Chief Physician of Orthopaedics, Trauma Surgery and Spine Surgery Prof. Großterlinden.

Erfahren Sie mehr auf unserer Website: http://www.asklepios.com/ Abonnieren Sie den YouTube-Kanal der Asklepios-Kliniken: https://www.youtube.com/user/Asklep...

18/11/2019

Last week, a medical event was held for urologists on the subject of fluorescence cystoscopy. The intravesical administration of Hexvix before the operation stimulates the fluorescence of tumor tissue and presents it with a special endoscopy technique (PDD technique). In addition, the team around Prof. Dr. Wülfing demonstrated the da Vinci technology, retroperitoneoscopic kidney interventions and incontinence and neurostimulation of the urinary bladder.

13/11/2019

Focus Top Clinics 2020": Altona in the ranking

We are ranked 52nd among the top 100 national clinics. The is also represented in the lists published according to treatment focus: Colon cancer, leukaemia, prostate cancer, gallbladder and bile duct surgery and risk births. The data for the ranking were collected in May/June 2019. The independent research institute MINQ interviews general practitioners, specialists and chief physicians of the relevant clinics. THANK YOU all, because you deserve it!
Here you can find the magazine for purchase:

FOCUS GESUNDHEIT Klinikliste 2020

30/10/2019

In northern Germany, we stand for interdisciplinary and cross-location top medicine in oncology.

With our seven Hamburg clinics for maximum and specialty care, we offer the largest, interdisciplinary spectrum with around 200 cancer experts.
In weekly tumour conferences, our experts work together to develop the optimal therapy for you and ensure that you can be treated close to your home.

24/10/2019

On e-scooters at 20 km/h - neurosurgeon and trauma surgeon appeal together: Protect your heads! Wear a helmet!

But at speeds of up to 20 km/h, a fall can lead to serious head injuries. Prof. Dr. Uwe Kehler, Chief Physician of Neurosurgery and Prof. Dr. Lars Gerhard Großterlinden, Chief Physician of Orthopaedics, Trauma and Spine Surgery at the Asklepios Clinic Altona in Hamburg, urgently warn of the risks and appeal not to use the e-scooters without a helmet.

Already 14-Jhrige can drive starting from coming month the new E-Scooter. Since these are permitted "only" up to a maximum speed of 20km/h, the legislator has prescribed an insurance cover, but no helmet obligation. "We already have many years of experience with cyclists who ride without a helmet and then come to our clinic with serious injuries," says the head physician of neurosurgery. "Typical head injuries such as craniocerebral trauma, cerebral hemorrhages, subdural or epidural hematomas or cerebral edema can be demonstrably prevented in part or even completely by wearing helmets". The consequences of such injuries range from headaches, concentration disorders, epileptic seizures, paralysis, speech disorders to the need for long-term care, coma vigil and death. "And indeed, children and adolescents are even more at risk than adults. They are less attentive and anticipatory and take more risks," warns Prof. Dr. Kehler.

A study from the USA recently published by the Centers for Disease Control and Prevention (CDC) confirms the high risk of head injuries when using e-scooters. Injuries were investigated in the Texas capital Austin between September and November 2018. Of the 190 injured e-scooter drivers identified there, 45 percent suffered head injuries. Virtually no driver wore a helmet. "As we know from our experience in other countries, e-scooters are simply not harmless despite all the driving fun," warns the Chief Physician of Orthopaedics, Trauma and Spine Surgery. For example, 70 percent of the E-scooter drivers involved in accidents in Austin suffered injuries to their upper limbs such as hands, wrists, arms and shoulders, while 55 percent suffered injuries to their lower limbs.

"I hope that what is now common practice among skiers will also become established among future e-scooters from the very beginning: Protect your head! Wear a helmet", Prof. Dr. Kehler therefore appeals urgently. "And the adults have a decisive role model function in this respect.

15/10/2019

Research work by urologist at Asklepios Clinic Altona awarded Maximilian Nitze Prize

Klaus-Peter Dieckmann, Medical Director of the Testicular Tumor Center Hamburg in the Asklepios Clinic Altona, and biologists from the University of Bremen were awarded the Maximilian Nitze Prize by the German Society for Urology (DGU) for their many years of research and discovery of the tumor marker M371 for testicular cancer. The prize is awarded for outstanding scientific achievements in experimental or clinical urology.

The team with the urologist Prof. Dr. med. Klaus-Peter Dieckmann has discovered a new tumor marker for testicular cancer in the blood and demonstrated its high significance for diagnostics, therapy and aftercare in studies. Tumour markers are measurable substances that are released into the blood by cancer cells and are elevated in cancer patients.

Testicular cancer is the most common tumor disease in men between the ages of 20 and 40, which is why it is also referred to as "the cancer of the young man". Approximately 4000 men contract the disease every year in Germany, in Hamburg alone the figure is about 200 men per year. The number of illnesses has been rising for years. The reason for this is not known, but environmental influences are suspected.

As early as 2012, the research team was able to report on the new tumour marker in testicular tumours in a preliminary study. The result of several years of follow-up studies is now a method for the reliable determination of this marker. Dieckmann's urologists were able to show that even very small tumours with a diameter of less than 1 cm release the signalling substance M371. "This is a great step forward," said Dieckmann, "because the M371 test can be used in more than 90% of all testicular tumours. The previous marker substances are only pronounced in about 50% of all patients. The new test helps in the early detection, in the spread diagnosis, in the examination of the therapy success and above all in the early detection of relapses. We also believe that many of the harmful, stressful and expensive X-ray examinations that are carried out with the test are no longer necessary during aftercare".

In the urology department of the Asklepios Clinic Altona Prof. Dr. Dieckmann and the team of the Testicular Tumor Center treat about 80-100 patients annually with all stages of testicular cancer, whereby all chemotherapies and surgical interventions are performed here. After the success, which the renowned American "Journal of Clinical Oncology" has also reported on in detail, the research team is now working together with biologists from the University of Bremen to create a so-called "laboratory kit" for practical application, which can then be used in testicular cancer patients in clinical everyday life. This is expected to happen in the course of next year.

08/10/2019

Prof. Dr. S. Alsalameh takes over Rheumatology Altona

On 1 October 2019, Prof. Dr. Saifeddin Alsalameh will take over as Head of Rheumatology and Clinical Immunology at the Asklepios Clinic Altona and, in cooperation with other specialist departments, expand the medical range to include multidisciplinary osteology (bone medicine). Under the umbrella of oncology and haematology (head physician Prof. Dr. Dirk Arnold) and in close interdisciplinary cooperation with the other medical departments and centres of the hospital at the highest level of care, the Rheumatology and Clinical Immunology section is to be further expanded in future.

Prof. Dr. Saifeddin Alsalameh (63) is a specialist in internal medicine/rheumatology and a specialist immunologist of the German Society of Immunology and Osteology. He previously worked at the Friedrich-Alexander-University Erlangen/Nuremberg, the University of California San Diego (UCSD), the University of Arkansas for Medical Sciences (UAMS), The Scripps Research Institute (TSRI) and Scrips Clinics in La Jolla/San Diego in California, USA, as head of the outpatient clinic for rheumatology, immunology and osteology at the UKE and as a resident specialist. Alsalameh has also headed the Department of Internal Medicine/Rheumatology at Tawam Hospital (Abu Dhabi), associated with the renowned Johns Hopkins University, and worked at Mafraq Hospital (Abu Dhabi), the Sidra Medical and Research Center (SMRC) and the French-headed Aspitar Specialty Athlete Hospital in Doha, Qatar.

"We are very pleased to have gained Prof. Alsalameh, a renowned specialist with such extensive international experience for our clinic", emphasizes Prof. Dr. Volker Ragosch, Medical Director of the Asklepios Klinik Altona: "Patient demand in this area is very high and the important Department of Internal Rheumatology and Clinical Immunology has many intersections with almost all other disciplines of a large hospital such as the Asklepios Klinik Altona". To the emphasis of the section belong apart from the inflammatory joint illnesses any immune defects and autoimmune diseases, vessel inflammations (Vaskulitiden), memory diseases, collagenosen, soft part rheumatism tables illnesses such as Fibromyalgie, Osteoporose as well as pregnancy and desire for children with rheumatism patients apart from the inflammatory joint illnesses.

06/09/2019

A renowned oncologist on the current state of research and patient care in Hamburg.

In 20 years cancer will be curable. At least that is what Federal Health Minister Jens Spahn promised a few weeks ago. Professor Dr. Dirk Arnold, medical director of the Asklepios Tumour Centre in Hamburg and internationally renowned oncologist, is more cautious in this respect than the CDU politician. "This is, of course, a very provocative thesis. But the minister is right: We must try to cure even more patients. And we have to be able to talk about cancer without taboos," says the habilitated physician.

At the Asklepios Tumor Center in Hamburg alone, which brings together the expertise of more than 200 specialists from seven clinics, 16,000 new patients present themselves every year. Nationwide, cancer with its approximately 100 different types, which are then also divided into multiple subtypes, is the second most frequent cause of death after cardiovascular diseases, 230,000 people die of it every year. "The challenge is that although tumour diseases are very widespread and a mass phenomenon, they also require a high degree of specialisation in treatment.

27 tumour conferences per week

But how does such a center with different locations function in purely organizational terms? The situation of a cancer patient is regularly discussed on tumour boards with all relevant specialists at the centre, some of whom are then connected to the centre via video. Every week, 27 of these conferences, each lasting an average of 25 to 40 minutes, are held at the Asklepios Tumour Centre. "Afterwards one has achieved a broad mood picture and usually also a consensus. In the next step, we then introduce the patient and his relatives to what we propose as further steps. Because nothing happens without the consent of those affected."

05/08/2019

Do you want to become a doctor? - High school graduates test their career aspirations with a Hamburg-wide unique project
Already for the fourth time the Asklepios clinic Altona offers with the Hamburg far unique project Schnupperpraktikum physician high school graduates the possibility before the medicine study the vocational profile to become acquainted. We close thereby a gap in the practical course offer for pupils, because pupil practical courses are not offered by medical side, hospitals offer only practical courses in the care. In the next five days the high school graduates will get to know various disciplines such as gynaecology and obstetrics, urology, neurology, trauma surgery and radiology, spend time in the operating theatre and intensive care unit, listen to various lectures and gain their first practical experience with phantoms. This also includes a discussion with medical students. Prof. Dr. Schmidt, initiator of the project: "We would like to give the students the chance to get an impression of what studying and working life is like for a medical student, how diverse and exciting the profession is. We can strengthen or motivate students who are still insecure in their desire to find a way to realize their dream job, perhaps despite high hurdles. At the same time, we may keep others energized by something that isn't right after all." We wish the participants exciting impressions, great experiences and ... maybe we will see you again later as a medical student or future colleague.